BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35216960)

  • 1. A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometry.
    Ozdemir ZN; Falay M; Parmaksiz A; Genc E; Beyler O; Gunes AK; Ceran F; Dagdas S; Ozet G
    Hematol Transfus Cell Ther; 2023; 45(2):176-181. PubMed ID: 35216960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which Markers Should the used for Diagnostic Chronic Lymphocytic Leukemia Immunophenotyping Scoring System by Flow Cytometry?
    Falay M; Serdar MA; Dalgali H; Uçar MA; Dagdaş S; Özet G
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia.
    Li W; Fang P; Fu G; Liang H; Peng M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1689-1694. PubMed ID: 36748379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.
    Li Y; Tong X; Huang L; Li L; Wang C; He C; Liu S; Wang Z; Xiao M; Mao X; Zhang D
    Cancer Med; 2021 Jul; 10(13):4387-4396. PubMed ID: 34061467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma.
    Falay M; Afacan Öztürk B; Güneş K; Kalpakçı Y; Dağdaş S; Ceran F; Özet G
    Turk J Haematol; 2018 May; 35(2):94-98. PubMed ID: 28713070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms.
    Starostka D; Kriegova E; Kudelka M; Mikula P; Zehnalova S; Radvansky M; Papajik T; Kolacek D; Chasakova K; Talianova H
    Cytometry B Clin Cytom; 2018 Jul; 94(4):576-587. PubMed ID: 29220870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
    Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project.
    Rawstron AC; Kreuzer KA; Soosapilla A; Spacek M; Stehlikova O; Gambell P; McIver-Brown N; Villamor N; Psarra K; Arroz M; Milani R; de la Serna J; Cedena MT; Jaksic O; Nomdedeu J; Moreno C; Rigolin GM; Cuneo A; Johansen P; Johnsen HE; Rosenquist R; Niemann CU; Kern W; Westerman D; Trneny M; Mulligan S; Doubek M; Pospisilova S; Hillmen P; Oscier D; Hallek M; Ghia P; Montserrat E
    Cytometry B Clin Cytom; 2018 Jan; 94(1):121-128. PubMed ID: 29024461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200.
    Köhnke T; Wittmann VK; Bücklein VL; Lichtenegger F; Pasalic Z; Hiddemann W; Spiekermann K; Subklewe M
    Br J Haematol; 2017 Nov; 179(3):480-487. PubMed ID: 28832948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study.
    Sorigue M; Junca J; Ferra C; Marce S; Ruiz-Xivillé N; Pinyol L; Cabezon M; Espasa A; Dominguez D; Lopez-Viaplana L; Ruiz R; Buch J; Plensa E; Mostacedo SZ; Aranda J; Vergara S; Raya M; Granada I; Tapia G; Navarro JT; Beà S; Zamora L
    Cytometry B Clin Cytom; 2020 Sep; 98(5):421-428. PubMed ID: 32530577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Sun Y; Wang SA; Sun T
    Cytometry B Clin Cytom; 2018 Jan; 94(1):148-150. PubMed ID: 28109040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders.
    Al-Zubaidi HK; Hughes SF
    Br J Biomed Sci; 2023; 80():11573. PubMed ID: 37822353
    [No Abstract]   [Full Text] [Related]  

  • 13. CD200 expression in B-cell chronic lymphoproliferative disorders.
    El Desoukey NA; Afify RA; Amin DG; Mohammed RF
    J Investig Med; 2012 Jan; 60(1):56-61. PubMed ID: 22064604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotyping of Chronic Lymphocytic Leukemia.
    Falay M; Özet G
    Clin Lab; 2017 Oct; 63(10):1621-1626. PubMed ID: 29035453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of CD200 to the diagnostic accuracy of Matutes score in the diagnosis of chronic lymphocytic leukemia in limited resources laboratories.
    Jalal SD
    PLoS One; 2021; 16(2):e0247491. PubMed ID: 33606850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of immunophenotyping in differential diagnosis of chronic lymphocytic leukemia.
    Ivancević TD; Kurtović NK; Knezević V; Bogdanović A; Mihaljević B; Bozić B; Gotić M
    Srp Arh Celok Lek; 2014; 142(3-4):197-203. PubMed ID: 24839775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia.
    D'Arena G; Vitale C; Rossi G; Coscia M; Omedè P; D'Auria F; Statuto T; Valvano L; Ciolli S; Gilestro M; Molica S; Bellesi S; Topini G; Panichi V; Autore F; Innocenti I; Musto P; Deaglio S; Laurenti L; Del Vecchio L
    Hematol Oncol; 2018 Mar; ():. PubMed ID: 29602219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL).
    Monaghan SA; Peterson LC; James C; Marszalek L; Khoong A; Bachta DJ; Karpus WJ; Goolsby CL
    Cytometry B Clin Cytom; 2003 Nov; 56(1):30-42. PubMed ID: 14582135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotyping of chronic B-cell neoplasms: flow cytometry versus immunohistochemistry.
    Abdel-Ghafar AA; El Din El Telbany MA; Mahmoud HM; El-Sakhawy YN
    Hematol Rep; 2012 Jan; 4(1):e3. PubMed ID: 22567217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differential malignant lymphoproliferative syndrome (LPS) diagnosis with flow cytometry: a study of 100 patients].
    Cardile N; Sabo G; Butsch P; Brengarth E; Viollier AF; Knecht H
    Praxis (Bern 1994); 2000 Jan; 89(4):143-9. PubMed ID: 10686807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.